2011 Fast Lane Honoree Algae Bio expands production facilities

In a region that is rapidly becoming known as a mecca for the natural resource industry with potash, solar and wind energy, another resource, algae, is now gaining notice. Six years ago Andrew Ayers bought 70 acres of land in an area east of Holbrook known as Adamana, believing it held something that to him was more precious than gold. In the vast open desert of northeastern Arizona Ayers discovered that beneath the surface lay pure salt water, and that salt water is ideal for Ayers’ research in macro algae.Continue reading

‘Dream Team’ stands up to melanoma cancer

 December 14, 2011:

Joe Caspermeyer, Biodesign Institute via http://asunews.asu.edu/20111214_melanomadreamteam

ASU’s Deirdre Meldrum and Joshua LaBaer, of the Biodesign Institute, have been named to the new Melanoma Dream Team created by Stand Up to Cancer, the Melanoma Research Alliance and the American Association for Cancer Research (AACR). The collaborative Dream Team project, involving scientists from top research institutions across the country, is focused on developing targeted, personalized therapies for a subtype of skin cancer that is difficult to treat. The Translational Genomics Research Institute (TGen) and the Barbara Ann Karmanos Cancer Institute will lead the $6 million national and international study.Continue reading

Peoria Mayor Welcomes the addition of new Medical Device and Bioscience Incubator

As seen in the Arizona Republic on 11/18/2011

Peoria will soon play host to bioscience startups, with the lofty long-term  goal of becoming a bioscience hub focused on medical devices that would bring  high-paying jobs to the city.

The Peoria City Council on Tuesday night unanimously approved a partnership  with BioAccel, a Phoenix non-profit that mentors startups, as well as Plaza  Companies of Peoria, which would host the Peoria Incucelerator. The name comes  from the combination of incubator and accelerator.Continue reading

NEW NCI SBIR Phase II Bridge Award: Bridging the Valley of Death

The National Cancer Institute (NCI) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs has announced the FY2012 SBIR Phase II Bridge Award, designed to support the next stage of development for previously funded NIH-wide SBIR Phase II projects in the areas of cancer therapeutics, imaging technologies, interventional devices, diagnostics and prognostics. The NCI intends to commit up to $10 million in fiscal year 2012 to fund up to ten new awards.Continue reading

Luceome Biotechnologies Receives $1.9 Million in Phase I and Phase II SBIR Funding to Advance its High Throughput Screening Platform

TUCSON, AZ – LUCEOME BIOTECHNOLOGIES a privately held biotechnology company focused on the discovery and development of its innovative proprietary assay platform today announced the award of $1.6 million in grant funding from The National Institutes of Health to further their research in high throughput screening using the KinaseSeeker™ technology. Earlier this year, Luceome was awarded a grant for $287K for research in the area of poly(ADP-ribose) detection.

Continue reading